Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:12 PM
Ignite Modification Date:
2025-12-24 @ 1:12 PM
NCT ID:
NCT01189695
Eligibility Criteria:
Inclusion Criteria:
* age 18-60 years
* documented HIV infection
* previously failed to NNRTI-based regimens
* no history of failing PI-based regimens
* receiving ritonavir-boosted PI + OBRs(such as NRITs, etravirine, raltegravir)
* having HIV-1 RNA \<50 copies/ml for at least prior 6 months
Exclusion Criteria:
* Pregnant or breastfeeding woman
* HBV co-infection that had to treated with TDF, FTC or 3TC
* had to received medications known to have potential significant drug interaction with LPV/r
* life expectancy less than 6 months
* serious systemic diseases such as liver cirrhosis Child-Pugh B/C, ESRD, malignancy
* hemoglobin \<8 g/dl, platelet \<50,000/mm3, AST or ALT \>3 ULN, estimated creatinine clearance \<50 mL/min
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT01189695
Study Brief:
Protocol Section:
NCT01189695